Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-24 @ 9:14 PM
NCT ID:
NCT00238004
Eligibility Criteria:
Inclusion Criteria:
* Persisting low HDL-C (\<0.9mmol/l) on a full lipid profile result (which for inpatients should have been taken \<24 hours after admission).
* Objective diagnosis of coronary heart disease (previous biomarker proven MI, positive stress test, angiogram with at least one \>50% diameter stenosis)
* Established for at least 6 weeks on a "maintenance" dose of statin therapy (defined as Pravastatin 40mg, Simvastatin 40mg or Atorvastatin ≥10mg). The dose and type of statin should not be altered during the study period
* Absence of concurrent major systemic illness (particularly liver or renal failure, or hypo or hyperthyroidism)
Exclusion Criteria:
* Previous use of Niaspan or other non-statin lipid lowering agent within the previous 12 weeks
* Contraindications to Niaspan therapy
* Participation in another medical trial within the previous 30days
* Failure to obtain informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00238004
Study Brief:
Protocol Section:
NCT00238004